Perinatal group B streptococcal disease after universal screening recommendations - United States, 2003-2005

Morbidity and Mortality Weekly Report

Volumn 56, Issue 28, 2007, Pages 701-705

  Reingold, A ^a   Gershman, K ^b   Petit, S ^c   Arnold, K ^d   Harrison, L ^e   Lynfield, R ^f   Albanese, B ^g   Zansky, S ^h   Thomas, A ⁱ   Craig, A ^j   Schrag, S J ^k   Zell, E R ^k   Lewis, P ^k   Patel, R M ^l  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Colorado Dept of Public Health ^*  (United States)

^c CDC   (United States)

^d GEORGIA DEPARTMENT OF HUMAN RESOURCES   (United States)

^e Maryland Emerging Infections Program   (United States)

^f MINNESOTA DEPARTMENT OF HEALTH   (United States)

^g New Mexico Dept of Health ^*  (Mexico)

^h NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

ⁱ OREGON PUBLIC HEALTH DIVISION   (United States)

^j TENNESSEE DEPARTMENT OF HEALTH   (United States)

^k NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^l CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; DISEASE TRANSMISSION; FEMALE; HUMAN; INCIDENCE; INFANT; MASS SCREENING; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; UNITED STATES;

ADULT; ANTIBIOTIC PROPHYLAXIS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; UNITED STATES;

EID: 34447500580     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (9)

1. CDC. Prevention of perinatal group B streptococcal disease: revised recommendations from CDC. MMWR 2002;51(No. RR-11).
2. Little RJ, Rubin DB. Statistical analysis with missing data. 2nd ed. Wiley series in probability and statistics. Hoboken, NJ: Wiley & Sons; 2002.
3. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
4. CDC. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996;45(No. RR-7).
5. Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9.
6. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20.
7. Stapleton RD, Kahn JM, Evans LE, et al. Risk factors for group B streptococcal genitourinary tract colonization in pregnant women. Obstet Gynecol 2005;106:1246-52.
8. Schuchat A, Oxtoby M, Cochi S, et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 1990;162:672-7. 9. CDC. Diminishing racial disparities in early-onset neonatal group B streptococcal disease - United States, 2002-2003. MMWR 2004;53:502-5.
9. Heath PT, Feldman RG. Vaccination against group B streptococcus. Expert Rev Vaccines 2005;4:207-18.